Medigene AG maintained financial guidance for the fiscal year 2023. The Company maintains its guidance on expected revenues to be between EUR 5 and 7 million in 2023 (unchanged).
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.503 EUR | -2.40% | +0.32% | +1.97% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+1.97% | 40.77M | |
+10.44% | 107B | |
+0.82% | 106B | |
+8.44% | 23.47B | |
-13.89% | 21.9B | |
-6.08% | 18.77B | |
-37.26% | 17.85B | |
-10.98% | 16.78B | |
+8.67% | 14.41B | |
+41.08% | 12.86B |
- Stock Market
- Equities
- MDG1 Stock
- News Medigene AG
- Medigene AG Maintains Financial Guidance for the Fiscal Year 2023